Search
for
Sort by
Research 481–510 of 1000+
- Uncertainty, Anxiety and Isolation: Experiencing the COVID-19 Pandemic and Lockdown as a Woman with Polycystic Ovary Syndrome (PCOS)
- Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
- Trends in dermatological presentations at the emergency department of a tertiary hospital in Singapore: a 4-year analysis pre- and during COVID-19
- The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial
- Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan
- How coronavirus disease 2019 vaccination affect the level of vitamin D in serum and hair?
- Epidemiological Analysis of Alopecia in Migrant Communities at Dr. Hair™ Clinics
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort
- Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results of a Prospective Multicenter Cohort
- Facial Dermatoses in the Age of Masks: Acne, Eczema and the New Maskne
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- The role of sleep in telogen effluvium and trichodynia: A commentary in the context of the current pandemic
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- ASSESSMENT OF THE RISK OF DEVELOPING ALOPECIA IN PATIENTS AFTER CORONAVIRAL INFECTIONAND EFFECTIVE TREATMENT METHODS
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- Application of Kampo Medicines for Treatment of General Fatigue Due to Long COVID
- Pathophysiological Mechanisms in Long COVID: A Mixed Method Systematic Review
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- The Multisystem Impact of Long COVID: A Comprehensive Review
- Long-COVID symptoms after multisystem inflammatory syndrome in children during different pandemic waves
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Serum Levels of VWF, t-PA, TNF-α, and ICAM-1 in Patients Receiving Hemocoagulase Combined with Platelet-Rich Plasma during Total Hip Replacement
- Postoperative complicated appendectomy revealing Crohn’s disease in a pediatric patient
- Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study